Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,396 | -23,255 | -19,773 | -15,769 | -12,578 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 597 |
| Accounts payable and accrued liabilities | 520 | -119 | 472 | 211 | 806 |
| Other Working Capital | 1,499 | -1,238 | 3,086 | 353 | 1,126 |
| Other Operating Activity | 1,533 | 8,907 | 3,144 | 3,109 | 5,927 |
| Operating Cash Flow | $-18,845 | $-15,705 | $-13,071 | $-12,096 | $-4,123 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 7,369 |
| Debt Repayment | N/A | N/A | N/A | N/A | 63 |
| Common Stock Issued | 18,524 | 18,972 | 11,418 | 14,443 | 6,281 |
| Other Financing Activity | -617 | -795 | -2,148 | -1,966 | 322 |
| Financing Cash Flow | $17,907 | $18,177 | $9,271 | $12,477 | $14,034 |
| Exchange Rate Effect | -5 | -22 | 0 | -4 | 0 |
| Beginning Cash Position | 9,601 | 7,151 | 10,951 | 10,574 | 664 |
| End Cash Position | 8,658 | 9,601 | 7,151 | 10,951 | 10,574 |
| Net Cash Flow | $-943 | $2,451 | $-3,800 | $377 | $9,911 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,845 | -15,705 | -13,071 | -12,096 | -4,123 |
| Free Cash Flow | -18,845 | -15,705 | -13,071 | -12,096 | -4,123 |